Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective
Ranjan K. Mohapatra, Venkataramana Kandi, Sarika Verma, et al.
ChemBioChem (2022) Vol. 23, Iss. 9
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 139
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
Ranjan K. Mohapatra, Venkataramana Kandi, Ashish K. Sarangi, et al.
International Journal of Surgery (2022) Vol. 103, pp. 106698-106698
Open Access | Times Cited: 93
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 4, pp. 101346-101346
Open Access | Times Cited: 35
EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19
Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 337-343
Closed Access | Times Cited: 7
The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
Lidia Sánchez‐Morales, José Manuel Sánchez‐Vizcaíno, Marta Pérez‐Sancho, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 29
SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods
Giulia Berno, Lavinia Fabeni, Giulia Matusali, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1058-1058
Open Access | Times Cited: 28
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Computational studies on potential new anti-Covid-19 agents with a multi-target mode of action
Ranjan K. Mohapatra, Mohammad Azam, Pranab Kishor Mohapatra, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 5, pp. 102086-102086
Open Access | Times Cited: 25
Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: A discussion
Ranjan K. Mohapatra, Ahmed Mahal, L. V. Simhachalam Kutikuppala, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 19
Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats
Samy M. El‐Megharbel, Safa H. Qahl, Bander Albogami, et al.
PeerJ (2024) Vol. 12, pp. e15638-e15638
Open Access | Times Cited: 3
The impact of Omicron on the COVID-19 vaccines: A review
Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, et al.
Vacunas (2024) Vol. 25, Iss. 2, pp. 274-284
Closed Access | Times Cited: 3
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Ranjan K. Mohapatra, Snehasish Mishra, Venkataramana Kandi, et al.
Health Science Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 9
Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group
Giuseppe Lippi, Julien Favresse, M. Michael Gromiha, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 7, pp. 975-981
Open Access | Times Cited: 15
Emerging novel sub-lineage BA.2.75: The next dominant omicron variant?
Ranjan K. Mohapatra, Venkataramana Kandi, Snehasish Mishra, et al.
International Journal of Surgery (2022) Vol. 104, pp. 106835-106835
Closed Access | Times Cited: 14
Global domination of the recently VoI-classified 'JN.1′ outcompeting other variants – Comparing the vaccines’ efficacy
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 2
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 13
Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
Cong Xu, Jue Wang, Lili Yu, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 6
As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
Ren Xu, Wanning Wang, Wenlong Zhang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 9
Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages
Naveen Kumar, Rahul Kaushik, Ashutosh Singh, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2764-2764
Open Access | Times Cited: 7
Targeting Omicron (B.1.1.529) SARS CoV-2 spike protein with selected phytochemicals: an in-silico approach for identification of potential drug
Hardeep Singh Tuli, Poonam Bansal, Varruchi Sharma, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 2, pp. 396-404
Open Access | Times Cited: 6
Positively bound: Remapping of Increased Positive Charge Drives SARS-CoV-2 Spike Evolution to Optimize its Binding to Cell Surface Receptors
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
(2022)
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top